CSTL - Financial Reports List - Castle Biosciences, Inc. - IntrinsicAlpha

Castle Biosciences, Inc. CSTL

Healthcare - Medical - Diagnostics & Research - NASDAQ - US

$ 22.0

-1.72 %

$ 635 M

Market Cap

34.1

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	30.54%	471.71%	171.58%
Annual Report	FY	10-K	2024-12-31	51.09%	131.75%	112.75%
Quarterly Report	Q3	8-K	2024-09-30	39.50%	132.86%	152.69%
Quarterly Report	Q2	8-K	2024-06-30	73.53%	147.50%	123.69%
Quarterly Report	Q1	8-K	2024-03-31	73.59%	91.32%	82.64%
Quarterly Report	Q4	8-K	2023-12-31	72.47%	87.49%	75.54%
Annual Report	FY	10-K	2023-12-31	60.38%	14.41%	25.42%
Quarterly Report	Q3	8-K	2023-09-30	66.15%	63.29%	55.55%
Quarterly Report	Q2	8-K	2023-06-30	43.92%	-1039.38%	13.18%
Quarterly Report	Q1	8-K	2023-03-31	56.55%	-18.60%	-28.58%

1